Spineology Finishes Enrollment in Postmarket Lateral Implant Trial
Minnesota-based Spineology has completed enrollment in a postmarket trial of its Duo expandable interbody-fusion system for the treatment of spinal disorders.
The 200-patient trial is following subjects for two years to assess the short- and long-term outcomes of their implant procedures. Early data from 115 participants showed the system offered benefits over alternative fusion systems, the company said.
The Duo system is placed through an 18mm tube and is then expanded and filled with bone graft to provide a large, load-bearing support.